581 related articles for article (PubMed ID: 36854773)
1. The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implications.
Liu Z; Gao L; Cheng L; Lv G; Sun B; Wang G; Tang Q
Exp Mol Med; 2023 Mar; 55(3):487-501. PubMed ID: 36854773
[TBL] [Abstract][Full Text] [Related]
2. Novel insights into the interaction between N6-methyladenosine methylation and noncoding RNAs in musculoskeletal disorders.
Han J; Kong H; Wang X; Zhang XA
Cell Prolif; 2022 Oct; 55(10):e13294. PubMed ID: 35735243
[TBL] [Abstract][Full Text] [Related]
3. N6-methyladenosine (m6A) modification in osteosarcoma: expression, function and interaction with noncoding RNAs - an updated review.
Zhang Y; Xu Y; Bao Y; Luo Y; Qiu G; He M; Lu J; Xu J; Chen B; Wang Y
Epigenetics; 2023 Dec; 18(1):2260213. PubMed ID: 37766615
[TBL] [Abstract][Full Text] [Related]
4. Unraveling the cross-talk between N6-methyladenosine modification and non-coding RNAs in breast cancer: Mechanisms and clinical implications.
Liu X; Xie X; Sui C; Liu X; Song M; Luo Q; Zhan P; Feng J; Liu J
Int J Cancer; 2024 Jun; 154(11):1877-1889. PubMed ID: 38429857
[TBL] [Abstract][Full Text] [Related]
5. The interplay between m6A RNA methylation and noncoding RNA in cancer.
Ma S; Chen C; Ji X; Liu J; Zhou Q; Wang G; Yuan W; Kan Q; Sun Z
J Hematol Oncol; 2019 Nov; 12(1):121. PubMed ID: 31757221
[TBL] [Abstract][Full Text] [Related]
6. Interaction between m6A and ncRNAs and Its Association with Diseases.
Chen S; Dong J; Luo X; Nie Z; Lu S; Liu H; Liu J
Cytogenet Genome Res; 2022; 162(4):171-187. PubMed ID: 36122561
[TBL] [Abstract][Full Text] [Related]
7. The role of m6A epigenetic modifications in tumor coding and non-coding RNA processing.
Wen T; Li T; Xu Y; Zhang Y; Pan H; Wang Y
Cell Commun Signal; 2023 Dec; 21(1):355. PubMed ID: 38102645
[TBL] [Abstract][Full Text] [Related]
8. Novel Insights Into the Role of N6-Methyladenosine RNA Modification in Bone Pathophysiology.
Chen J; Tian Y; Zhang Q; Ren D; Zhang Q; Yan X; Wang L; He Z; Zhang W; Zhang T; Yuan X
Stem Cells Dev; 2021 Jan; 30(1):17-28. PubMed ID: 33231507
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk between m6A and coding/non-coding RNA in cancer and detection methods of m6A modification residues.
Meng Q; Schatten H; Zhou Q; Chen J
Aging (Albany NY); 2023 Jul; 15(13):6577-6619. PubMed ID: 37437245
[TBL] [Abstract][Full Text] [Related]
10. The relationship between the network of non-coding RNAs-molecular targets and N6-methyladenosine modification in tumors of urinary system.
Li R; Zhu C; Wang Y; Wang X; Wang Y; Wang J; Wang K
Cell Death Dis; 2024 Apr; 15(4):275. PubMed ID: 38632251
[TBL] [Abstract][Full Text] [Related]
11. The interplay between m6A modification and non-coding RNA in cancer stemness modulation: mechanisms, signaling pathways, and clinical implications.
Qin S; Mao Y; Wang H; Duan Y; Zhao L
Int J Biol Sci; 2021; 17(11):2718-2736. PubMed ID: 34345203
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk between N6-methyladenosine (m6A) modification and noncoding RNA in tumor microenvironment.
Wang D; Han Y; Peng L; Huang T; He X; Wang J; Ou C
Int J Biol Sci; 2023; 19(7):2198-2219. PubMed ID: 37151887
[TBL] [Abstract][Full Text] [Related]
13. N6-methyladenosine RNA modification and its interaction with regulatory non-coding RNAs in colorectal cancer.
Ge Y; Liu T; Wang C; Zhang Y; Xu S; Ren Y; Feng Y; Yin L; Pu Y; Liang G
RNA Biol; 2021 Nov; 18(sup2):551-561. PubMed ID: 34674600
[TBL] [Abstract][Full Text] [Related]
14. Circular RNAs, Noncoding RNAs, and N6-methyladenosine Involved in the Development of MAFLD.
Nakashima M; Suga N; Ikeda Y; Yoshikawa S; Matsuda S
Noncoding RNA; 2024 Feb; 10(1):. PubMed ID: 38392966
[TBL] [Abstract][Full Text] [Related]
15. Effect of circular RNAs and N6-methyladenosine (m6A) modification on cancer biology.
Zhang G; Hou J; Mei C; Wang X; Wang Y; Wang K
Biomed Pharmacother; 2023 Mar; 159():114260. PubMed ID: 36657303
[TBL] [Abstract][Full Text] [Related]
16. N6-methyladenosine RNA modification: A promising regulator in central nervous system injury.
Wang Q; Liang Y; Luo X; Liu Y; Zhang X; Gao L
Exp Neurol; 2021 Nov; 345():113829. PubMed ID: 34339678
[TBL] [Abstract][Full Text] [Related]
17. Research progress of N6-methyladenosine in colorectal cancer: A review.
Lin Y; Shi H; Wu L; Ge L; Ma Z
Medicine (Baltimore); 2023 Nov; 102(47):e36394. PubMed ID: 38013272
[TBL] [Abstract][Full Text] [Related]
18. N6-methyladenosine methyltransferases: functions, regulation, and clinical potential.
Huang W; Chen TQ; Fang K; Zeng ZC; Ye H; Chen YQ
J Hematol Oncol; 2021 Jul; 14(1):117. PubMed ID: 34315512
[TBL] [Abstract][Full Text] [Related]
19. RNA N6-methyladenosine methylation and skin diseases.
Yu Y; Lu S; Jin H; Zhu H; Wei X; Zhou T; Zhao M
Autoimmunity; 2023 Dec; 56(1):2167983. PubMed ID: 36708146
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk Between m6A RNA Methylation and miRNA Biogenesis in Cancer: An Unholy Nexus.
Jayasree PJ; Dutta S; Karemore P; Khandelia P
Mol Biotechnol; 2023 Oct; ():. PubMed ID: 37831403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
